Russia developing coronavirus antidote with a reported 99% efficacy rate!

on . Posted in Patriot News Network

MOSCOW, Russia (PNN) - January 7, 2021 - Russia has announced that it has developed an antidote against COVID-19 infections. The country’s medical regulator touted the new drug’s efficacy rate of “more than 99%” based on previous studies.

If clinical trials are successful, Russia’s new drug will be the first etiotropic COVID-19 medication - a treatment that directly targets the cause of a disease.

The Russian Federal Medical-Biological Agency (FMBA) said December 30 that its potential anti-COVID drug would become the world’s first direct-acting antiviral antidote. FMBA Head Veronika Skvortsova remarked, “This is the first etiotropic drug that directly affects the virus. In fact, this is an antidote for coronavirus infection.”

Skvortsova informed Russian Prime Minister Mikhail Mishustin that pre-clinical studies on the drug have been completed. The same studies have shown the antidote to be “completely safe” and “highly efficient”. She also told Mishustin that the FMBA is ready to apply for further permission to test out the drug.

“If clinical trials confirm the effectiveness of this drug - it will be the first safe, effective [and] direct-acting antiviral drug that has no analogs in the world,” Skvortsova commented. The drug has registered a more than 99% efficacy rate in clinical trials.

Aside from this new coronavirus antidote, the FMBA is also looking at a separate drug for treating more severe COVID-19 cases. The rheumatoid arthritis drug olokizumab, as retooled by Russian drugmaker R-Pharm, is said to be able to address cytokine storms in the body caused by SARS-CoV-2. A cytokine storm or hypercytokinemia is an immune response triggered by an overload of the body’s immune system to fight off the virus. Cytokine storms lead to body tissue damage and have been thought to cause the majority of COVID-19 fatalities.

R-Pharm Chief Medical Officer Mikhail Samsonov said back in October that the results of a clinical trial on olokizumab are set to be published. He also remarked that the drug has been included in national guidelines for treating COVID-19 patients - with promising results. “What we saw in the clinical trial and in clinical practice is that when we inject olokizumab [to patients], within a few hours the temperature is going down [and] oxygenation is growing,” Samsonov elaborated.

The two drugs - olokizumab and the etiotropic antidote - add to the growing number of medications that show promise against Wuhan coronavirus infections.

During the initial months of the “pandemic”, the anti-malaria drug hydroxychloroquine (HCQ) was found to be effective in fighting COVID-19. Fascist Police States of Amerika President Donald Trump even endorsed the use of the drug for treating COVID-19, which led to the Amerikan Gestapo Food and Drug Administration division (FDA) approving its use in March 2020.

However, the FDA revoked its initial authorization for HCQ in June 2020 after finding it “unlikely to be effective in treating COVID-19.” The regulatory agency cited “serious cardiac adverse effects and other potential serious side effects” with the use of HCQ as grounds for rescinding the drug’s approval.

The anti-parasitic oral drug ivermectin has also been found to be a promising COVID-19 medication. Originally used against parasitic worms, it initially saw use in Latin America to address COVID-19 symptoms. Florida-based pulmonologist Dr. Jean-Jacques Ratjer was one of the first doctors to prescribe ivermectin for severe COVID-19 patients.

Ratjer said that ivermectin, included in the World Health Organization‘s List of Essential Medicines, was soon adopted by some Broward County hospitals as part of their COVID-19 treatment protocols. He added that more than seven months later, “the success rate of the ivermectin-based protocol is now far superior to what it was in its early days.”

Aside from HCQ and ivermectin, antibody treatments have also been touted as an effective treatment for COVID-19. Banking on the FDA’s approval of convalescent plasma in August 2020, some pharmaceutical firms have focused on developing these alternatives for those who cannot tolerate vaccines well.

The polyclonal antibody cocktail developed by Regeneron saw initial use as a treatment when FPSA President Donald Trump contracted the coronavirus in October 2020. It was among the treatments administered to the president during his hospitalization at the Walter Reed National Military Medical Center. AstraZeneca commenced advanced trials on its antibody treatment in October, while Eli Lilly’s version has obtained emergency use approval from the FDA.

Eulogies

Eulogy for an Angel
1992-Dec. 20, 2005

Freedom
2003-2018

Freedom sm

My Father
1918-2010

brents dad

Dr. Stan Dale
1929-2007

stan dale

A. Solzhenitsyn
1918-2008

solzhenitsyn

Patrick McGoohan
1928-2009

mcgoohan

Joseph A. Stack
1956-2010

Bill Walsh
1931-2007

Walter Cronkite
1916-2009

Eustace Mullins
1923-2010

Paul Harvey
1918-2009

Don Harkins
1963-2009

Joan Veon
1949-2010

David Nolan
1943-2010

Derry Brownfield
1932-2011

Leroy Schweitzer
1938-2011

Vaclav Havel
1936-2011

Andrew Breitbart
1969-2012

Dick Clark
1929-2012

Bob Chapman
1935-2012

Ray Bradbury
1920-2012

Tommy Cryer
1949-2012

Andy Griffith
1926-2012

Phyllis Diller
1917-2012

Larry Dever
1926-2012

Brian J. Chapman
1975-2012

Annette Funnicello
1942-2012

Margaret Thatcher
1925-2012

Richie Havens
1941-2013

Jack McLamb
1944-2014

James Traficant
1941-2014

jim traficant

Dr. Stan Monteith
1929-2014

stan montieth

Leonard Nimoy
1931-2015

Leonard Nimoy

Stan Solomon
1944-2015

Stan Solomon

B. B. King
1926-2015

BB King

Irwin Schiff
1928-2015

Irwin Schiff

DAVID BOWIE
1947-2016

David Bowie

Muhammad Ali
1942-2016

Muhammed Ali

GENE WILDER
1933-2016

gene wilder

phyllis schlafly
1924-2016

phylis schafly

John Glenn
1921-2016

John Glenn

Charles Weisman
1954-2016

Charles Weisman

Carrie Fisher
1956-2016

Carrie Fisher

Debbie Reynolds
1932-2016

Debbie Reynolds

Roger Moore
1917-2017

Roger Moore

Adam West
1928-2017

Adam West

JERRY LEWIS
1926-2017

jerry lewis

HUGH HEFNER
1926-2017

Hugh Hefner

PROF. STEPHEN HAWKING
1942-2018

Hugh Hefner 

ART BELL
1945-2018

Art Bell

DWIGHT CLARK
1947-2018

dwight clark

CARL MILLER
1952-2017

Carl Miller

HARLAN ELLISON
1934-2018

Harlan Ellison

STAN LEE
1922-2018

stan lee

CARL REINER
1922-2020

Carl Reiner

SEAN CONNERY
1930-2020

dwight clark